Medical-device makers: 3 buys & 1 hold

Article Excerpt

Medical-device sales have suffered lately, partly because of the recession. As well, proposed reforms to the U.S. health-care system could limit or cut the amount that hospitals and clinics can recoup from insurance companies. This could leave them with less to spend on medical devices. However, these are essential products, so sales should rebound over the next few months, regardless of the recovery’s strength or the outcome of the health-care debate. Still, only three of these medical-device makers are buys right now. BAXTER INTERNATIONAL INC. $55 (New York symbol BAX; Conservative Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 602.7 million; Market cap: $33.1 billion; Price-to-sales ratio: 2.7; WSSF Rating: Average) makes medical equipment through three main divisions. BioScience (43% of 2008 sales), makes vaccines and drugs; Medical Delivery (37%) makes intravenous equipment and systems; and Renal (19%) makes dialysis equipment. Other products account for the remaining 1% of sales. Baxter spends about 7% of its revenue on research. The resulting new products…